Drug Patents owned by Powder Pharms

1. List of Zingo drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8540665 POWDER PHARMS Particle cassettes and processes therefor
Oct, 2029

(6 years from now)

US9358338 POWDER PHARMS Particle cassettes and processes therefor
Apr, 2035

(12 years from now)

US9370622 POWDER PHARMS Devices and methods for delivering particles
Sep, 2035

(12 years from now)

Drugs and Companies using LIDOCAINE HYDROCHLORIDE ingredient

Market Authorisation Date: 16 August, 2007

Treatment: Zingo intradermal injection system is a drug delivery system that is capable of delivering fine dry powdered lidocaine hydrochloride monohydrate for local anesthetic action; Zingo is a powder intradermal system that is capable of delivering fine dry powdered lidocaine hydrochloride monohydrate for local anesthetic action

Dosage: SYSTEM;INTRADERMAL

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in